Robert Kramer
Concepts (402)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Foreign Bodies | 13 | 2021 | 96 | 3.750 |
Why?
| Endoscopy, Gastrointestinal | 13 | 2023 | 203 | 3.080 |
Why?
| Esophagoscopy | 9 | 2019 | 184 | 1.810 |
Why?
| Esophagus | 10 | 2019 | 225 | 1.750 |
Why?
| Esophageal Stenosis | 6 | 2019 | 45 | 1.610 |
Why?
| Gastroenterology | 8 | 2023 | 159 | 1.330 |
Why?
| Dilatation | 3 | 2019 | 60 | 1.330 |
Why?
| Electric Power Supplies | 7 | 2021 | 48 | 1.310 |
Why?
| Gastroesophageal Reflux | 3 | 2023 | 234 | 1.260 |
Why?
| Cholangiopancreatography, Endoscopic Retrograde | 4 | 2023 | 180 | 1.120 |
Why?
| Methyl Parathion | 6 | 2012 | 6 | 1.110 |
Why?
| Eosinophilic Esophagitis | 8 | 2019 | 296 | 1.100 |
Why?
| Amphotericin B | 5 | 2010 | 29 | 1.070 |
Why?
| Insecticides | 5 | 2012 | 31 | 1.020 |
Why?
| Esophageal Diseases | 2 | 2019 | 24 | 1.010 |
Why?
| Polyenes | 3 | 2010 | 7 | 0.980 |
Why?
| Catheterization | 3 | 2019 | 159 | 0.960 |
Why?
| Pediatrics | 8 | 2018 | 980 | 0.960 |
Why?
| Gastrointestinal Diseases | 3 | 2017 | 182 | 0.920 |
Why?
| Quality Improvement | 6 | 2022 | 950 | 0.920 |
Why?
| Duodenoscopes | 2 | 2022 | 7 | 0.890 |
Why?
| Gastroenterologists | 1 | 2023 | 18 | 0.870 |
Why?
| Obesity, Morbid | 3 | 2023 | 197 | 0.870 |
Why?
| Clinical Competence | 4 | 2018 | 893 | 0.840 |
Why?
| Child | 39 | 2023 | 18414 | 0.830 |
Why?
| Bariatric Surgery | 2 | 2023 | 161 | 0.820 |
Why?
| Laparoscopy | 2 | 2023 | 398 | 0.790 |
Why?
| Ketorolac | 1 | 2021 | 16 | 0.760 |
Why?
| Endoscopy | 4 | 2021 | 246 | 0.760 |
Why?
| Magnets | 2 | 2018 | 15 | 0.730 |
Why?
| Intestine, Small | 2 | 2018 | 122 | 0.720 |
Why?
| Pancreatitis | 1 | 2021 | 107 | 0.720 |
Why?
| Child, Preschool | 23 | 2021 | 9116 | 0.700 |
Why?
| Pediatric Obesity | 2 | 2023 | 488 | 0.680 |
Why?
| Quarantine | 1 | 2020 | 24 | 0.670 |
Why?
| Colonoscopy | 3 | 2022 | 204 | 0.670 |
Why?
| Abdominal Pain | 2 | 2018 | 135 | 0.670 |
Why?
| Digestive System | 2 | 2020 | 27 | 0.670 |
Why?
| Fever | 1 | 2021 | 280 | 0.660 |
Why?
| Single-Balloon Enteroscopy | 1 | 2018 | 4 | 0.630 |
Why?
| Antifungal Agents | 3 | 2009 | 128 | 0.630 |
Why?
| Capsule Endoscopy | 3 | 2017 | 17 | 0.610 |
Why?
| Vascular Fistula | 2 | 2016 | 14 | 0.610 |
Why?
| Esophageal Fistula | 2 | 2016 | 17 | 0.610 |
Why?
| Bile Duct Diseases | 1 | 2018 | 15 | 0.600 |
Why?
| Self Expandable Metallic Stents | 1 | 2018 | 14 | 0.600 |
Why?
| Postoperative Complications | 5 | 2023 | 2128 | 0.590 |
Why?
| Fellowships and Scholarships | 2 | 2018 | 227 | 0.590 |
Why?
| Patient Safety | 2 | 2018 | 277 | 0.580 |
Why?
| Retrospective Studies | 17 | 2023 | 12550 | 0.550 |
Why?
| Humans | 66 | 2023 | 114686 | 0.550 |
Why?
| Esophageal pH Monitoring | 1 | 2016 | 23 | 0.540 |
Why?
| Electric Impedance | 1 | 2016 | 100 | 0.520 |
Why?
| Algorithms | 3 | 2018 | 1469 | 0.520 |
Why?
| Stomach | 2 | 2020 | 102 | 0.500 |
Why?
| Infant | 15 | 2021 | 7963 | 0.490 |
Why?
| Adolescent | 24 | 2023 | 17844 | 0.480 |
Why?
| Chronic Pain | 1 | 2018 | 210 | 0.480 |
Why?
| Anesthesia | 1 | 2016 | 117 | 0.470 |
Why?
| Hospitalization | 2 | 2021 | 1752 | 0.470 |
Why?
| Education, Medical, Graduate | 1 | 2018 | 368 | 0.470 |
Why?
| Duodenum | 1 | 2014 | 62 | 0.470 |
Why?
| Mucous Membrane | 1 | 2014 | 108 | 0.450 |
Why?
| Checklist | 1 | 2014 | 83 | 0.440 |
Why?
| Endoscopy, Digestive System | 2 | 2019 | 110 | 0.430 |
Why?
| Female | 40 | 2019 | 59507 | 0.410 |
Why?
| Cytochrome P-450 Enzyme System | 5 | 2012 | 108 | 0.400 |
Why?
| Gastrointestinal Hemorrhage | 2 | 2011 | 102 | 0.390 |
Why?
| Male | 35 | 2021 | 55596 | 0.380 |
Why?
| Eating | 6 | 2021 | 344 | 0.380 |
Why?
| Zona Glomerulosa | 3 | 2000 | 3 | 0.370 |
Why?
| Esophageal Motility Disorders | 1 | 2011 | 23 | 0.360 |
Why?
| Spectrum Analysis, Raman | 1 | 2010 | 41 | 0.360 |
Why?
| Angiotensin II | 3 | 2000 | 87 | 0.350 |
Why?
| Salicylic Acid | 1 | 2010 | 8 | 0.350 |
Why?
| Artifacts | 1 | 2010 | 114 | 0.350 |
Why?
| Caustics | 1 | 2010 | 7 | 0.350 |
Why?
| Candida albicans | 2 | 2007 | 50 | 0.340 |
Why?
| Burns, Chemical | 1 | 2010 | 25 | 0.340 |
Why?
| Jejunal Diseases | 1 | 2009 | 7 | 0.330 |
Why?
| Dermatologic Agents | 1 | 2010 | 57 | 0.330 |
Why?
| Food | 1 | 2011 | 160 | 0.330 |
Why?
| Gastrostomy | 3 | 2018 | 91 | 0.320 |
Why?
| Drug Contamination | 1 | 2009 | 52 | 0.320 |
Why?
| Hemorrhage | 3 | 2014 | 620 | 0.320 |
Why?
| Cholinesterase Inhibitors | 4 | 2003 | 24 | 0.320 |
Why?
| Fluorescence | 1 | 2009 | 148 | 0.310 |
Why?
| Cholinesterases | 3 | 2002 | 6 | 0.300 |
Why?
| Common Bile Duct | 1 | 2007 | 14 | 0.290 |
Why?
| Drugs, Generic | 1 | 2007 | 18 | 0.290 |
Why?
| Candidiasis | 1 | 2007 | 51 | 0.290 |
Why?
| Aldosterone | 2 | 2000 | 42 | 0.280 |
Why?
| Stents | 1 | 2010 | 475 | 0.270 |
Why?
| Fluoroscopy | 3 | 2018 | 139 | 0.260 |
Why?
| Calcium | 6 | 2003 | 1108 | 0.250 |
Why?
| Obesity | 3 | 2009 | 2508 | 0.250 |
Why?
| Prospective Studies | 5 | 2021 | 6220 | 0.250 |
Why?
| Gastrectomy | 2 | 2023 | 82 | 0.250 |
Why?
| Biopsy | 4 | 2019 | 1036 | 0.230 |
Why?
| Palliative Care | 1 | 2010 | 644 | 0.230 |
Why?
| Hospitals, Pediatric | 2 | 2021 | 480 | 0.230 |
Why?
| Patient Care Team | 3 | 2018 | 517 | 0.220 |
Why?
| Anastomotic Leak | 1 | 2023 | 27 | 0.220 |
Why?
| Rats, Sprague-Dawley | 7 | 2012 | 2218 | 0.220 |
Why?
| Rats | 15 | 2012 | 4958 | 0.210 |
Why?
| Treatment Outcome | 7 | 2023 | 9088 | 0.210 |
Why?
| Constriction, Pathologic | 1 | 2023 | 208 | 0.210 |
Why?
| Chromatography, High Pressure Liquid | 3 | 2012 | 470 | 0.200 |
Why?
| Patient Satisfaction | 2 | 2017 | 578 | 0.200 |
Why?
| Cohort Studies | 3 | 2018 | 4895 | 0.190 |
Why?
| Anti-Bacterial Agents | 1 | 2010 | 1481 | 0.190 |
Why?
| Consensus | 5 | 2022 | 537 | 0.190 |
Why?
| Extracellular Space | 2 | 2000 | 116 | 0.190 |
Why?
| Pancreatic Ducts | 1 | 2021 | 69 | 0.180 |
Why?
| Risk Assessment | 3 | 2018 | 2968 | 0.180 |
Why?
| Multiple Chemical Sensitivity | 1 | 1999 | 1 | 0.170 |
Why?
| Equipment Contamination | 1 | 2020 | 54 | 0.170 |
Why?
| Somatoform Disorders | 1 | 1999 | 37 | 0.160 |
Why?
| Emergencies | 2 | 2011 | 146 | 0.160 |
Why?
| Informed Consent | 2 | 2017 | 161 | 0.160 |
Why?
| Alarmins | 1 | 2019 | 25 | 0.160 |
Why?
| Kinetics | 5 | 2012 | 1551 | 0.160 |
Why?
| Alcohols | 1 | 1999 | 28 | 0.160 |
Why?
| Testosterone | 4 | 2012 | 343 | 0.160 |
Why?
| Adverse Outcome Pathways | 1 | 2018 | 3 | 0.160 |
Why?
| Disinfection | 1 | 2020 | 106 | 0.160 |
Why?
| Vomiting | 2 | 2010 | 123 | 0.150 |
Why?
| Tranexamic Acid | 1 | 2019 | 39 | 0.150 |
Why?
| Virtual Reality | 1 | 2019 | 38 | 0.150 |
Why?
| Epidermolysis Bullosa | 1 | 2018 | 41 | 0.150 |
Why?
| Operative Time | 1 | 2018 | 106 | 0.150 |
Why?
| Play and Playthings | 1 | 2018 | 30 | 0.150 |
Why?
| Seizures | 2 | 1999 | 340 | 0.150 |
Why?
| Esophageal Mucosa | 1 | 2018 | 17 | 0.150 |
Why?
| Diagnosis, Differential | 2 | 2018 | 1342 | 0.150 |
Why?
| Intestinal Mucosa | 2 | 2015 | 532 | 0.150 |
Why?
| Age Factors | 2 | 2016 | 2894 | 0.150 |
Why?
| Operating Rooms | 1 | 2018 | 86 | 0.140 |
Why?
| Disease Outbreaks | 1 | 2020 | 307 | 0.140 |
Why?
| Animals | 22 | 2019 | 31706 | 0.140 |
Why?
| Microsomes, Liver | 4 | 2012 | 55 | 0.140 |
Why?
| Gastritis | 1 | 2017 | 84 | 0.140 |
Why?
| Intestines | 2 | 2012 | 326 | 0.130 |
Why?
| Enteritis | 1 | 2017 | 82 | 0.130 |
Why?
| Creatine Kinase, MB Form | 1 | 2015 | 4 | 0.130 |
Why?
| Angiography | 1 | 2016 | 174 | 0.130 |
Why?
| Ischemic Preconditioning | 1 | 2015 | 28 | 0.130 |
Why?
| Burns | 1 | 2019 | 237 | 0.130 |
Why?
| Eosinophilia | 1 | 2017 | 186 | 0.120 |
Why?
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 26 | 0.120 |
Why?
| Myocardial Reperfusion Injury | 1 | 2015 | 95 | 0.120 |
Why?
| Administration, Cutaneous | 4 | 2003 | 117 | 0.120 |
Why?
| Patient Acceptance of Health Care | 1 | 2021 | 681 | 0.120 |
Why?
| Follow-Up Studies | 2 | 2017 | 4411 | 0.120 |
Why?
| Hydrogen-Ion Concentration | 2 | 2010 | 511 | 0.120 |
Why?
| Stomach Diseases | 1 | 2014 | 19 | 0.120 |
Why?
| Cathartics | 1 | 2014 | 11 | 0.120 |
Why?
| Quality Indicators, Health Care | 1 | 2017 | 287 | 0.120 |
Why?
| Young Adult | 6 | 2020 | 10469 | 0.120 |
Why?
| Time-to-Treatment | 1 | 2016 | 147 | 0.120 |
Why?
| Mitochondria | 2 | 2019 | 747 | 0.120 |
Why?
| Practice Guidelines as Topic | 2 | 2012 | 1395 | 0.110 |
Why?
| Ambulatory Care | 1 | 2018 | 478 | 0.110 |
Why?
| Creatinine | 1 | 2015 | 425 | 0.110 |
Why?
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 2 | 2003 | 3 | 0.110 |
Why?
| Linear Models | 1 | 2016 | 768 | 0.110 |
Why?
| Androstadienes | 1 | 2014 | 97 | 0.110 |
Why?
| Anus Diseases | 1 | 2013 | 7 | 0.110 |
Why?
| Pneumonia | 1 | 2019 | 568 | 0.110 |
Why?
| Predictive Value of Tests | 1 | 2018 | 1796 | 0.110 |
Why?
| Drug Resistance | 1 | 2014 | 158 | 0.110 |
Why?
| Diltiazem | 1 | 1993 | 23 | 0.110 |
Why?
| Administration, Oral | 3 | 2014 | 728 | 0.110 |
Why?
| Endoscopes, Gastrointestinal | 1 | 2013 | 12 | 0.110 |
Why?
| Fistula | 1 | 2013 | 26 | 0.110 |
Why?
| Failure to Thrive | 1 | 2013 | 32 | 0.110 |
Why?
| Injections, Intravenous | 3 | 2002 | 198 | 0.110 |
Why?
| Abscess | 1 | 2013 | 72 | 0.100 |
Why?
| Anal Canal | 1 | 2013 | 84 | 0.100 |
Why?
| Potassium | 1 | 1993 | 128 | 0.100 |
Why?
| Time Factors | 4 | 2019 | 6115 | 0.100 |
Why?
| Patient Education as Topic | 1 | 2017 | 680 | 0.100 |
Why?
| Intestinal Perforation | 1 | 2012 | 39 | 0.100 |
Why?
| Tertiary Care Centers | 1 | 2013 | 126 | 0.100 |
Why?
| Deglutition | 1 | 2012 | 58 | 0.100 |
Why?
| Preoperative Care | 1 | 2014 | 319 | 0.100 |
Why?
| Hydroxylation | 1 | 2012 | 29 | 0.100 |
Why?
| Oxidation-Reduction | 4 | 2012 | 923 | 0.100 |
Why?
| Infant, Newborn | 2 | 2020 | 5047 | 0.100 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2012 | 73 | 0.100 |
Why?
| Sulfur | 1 | 2012 | 46 | 0.100 |
Why?
| Registries | 1 | 2019 | 1768 | 0.100 |
Why?
| Celiac Disease | 1 | 2014 | 264 | 0.090 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 318 | 0.090 |
Why?
| Cardiac Surgical Procedures | 1 | 2015 | 414 | 0.090 |
Why?
| Monocytes | 2 | 2007 | 504 | 0.090 |
Why?
| Dopamine | 2 | 2003 | 236 | 0.090 |
Why?
| Isoenzymes | 1 | 2012 | 283 | 0.090 |
Why?
| Enteral Nutrition | 2 | 2010 | 160 | 0.090 |
Why?
| Anti-Inflammatory Agents | 1 | 2014 | 447 | 0.090 |
Why?
| Spectrophotometry | 2 | 2009 | 48 | 0.090 |
Why?
| Crohn Disease | 1 | 2013 | 196 | 0.090 |
Why?
| Emergency Service, Hospital | 1 | 2021 | 1815 | 0.090 |
Why?
| Triamcinolone | 1 | 2010 | 14 | 0.090 |
Why?
| Spectrometry, Fluorescence | 1 | 2010 | 157 | 0.090 |
Why?
| Injections, Intralesional | 1 | 2010 | 32 | 0.090 |
Why?
| Epilepsy | 2 | 1998 | 278 | 0.090 |
Why?
| United States | 4 | 2023 | 12183 | 0.090 |
Why?
| Esophageal Perforation | 1 | 2010 | 11 | 0.090 |
Why?
| Incidence | 1 | 2016 | 2313 | 0.090 |
Why?
| Disease Models, Animal | 1 | 2019 | 3535 | 0.080 |
Why?
| Colloids | 1 | 2010 | 56 | 0.080 |
Why?
| Multivariate Analysis | 1 | 2013 | 1430 | 0.080 |
Why?
| Trachea | 1 | 2011 | 224 | 0.080 |
Why?
| Acute Kidney Injury | 1 | 2015 | 638 | 0.080 |
Why?
| Sex Factors | 3 | 2013 | 1715 | 0.080 |
Why?
| Prednisolone | 1 | 2009 | 75 | 0.080 |
Why?
| Liver | 7 | 2014 | 1637 | 0.080 |
Why?
| Poisoning | 1 | 2010 | 110 | 0.080 |
Why?
| Microbial Sensitivity Tests | 2 | 2007 | 300 | 0.080 |
Why?
| Mass Spectrometry | 1 | 2012 | 633 | 0.080 |
Why?
| Esophagitis | 1 | 2009 | 65 | 0.080 |
Why?
| Aorta | 1 | 2011 | 386 | 0.080 |
Why?
| Risk Factors | 1 | 2021 | 8632 | 0.080 |
Why?
| Deglutition Disorders | 1 | 2010 | 118 | 0.080 |
Why?
| Logistic Models | 1 | 2013 | 1841 | 0.080 |
Why?
| Cattle | 3 | 2000 | 920 | 0.070 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2007 | 59 | 0.070 |
Why?
| Adult | 11 | 2022 | 30550 | 0.070 |
Why?
| Water | 1 | 2010 | 396 | 0.070 |
Why?
| Stimulation, Chemical | 2 | 2000 | 56 | 0.070 |
Why?
| Status Epilepticus | 1 | 1987 | 32 | 0.070 |
Why?
| Body Weight | 5 | 2006 | 869 | 0.070 |
Why?
| Receptors, Opioid, kappa | 2 | 2003 | 11 | 0.070 |
Why?
| PC12 Cells | 2 | 2003 | 37 | 0.070 |
Why?
| Eosinophils | 1 | 2009 | 278 | 0.070 |
Why?
| Models, Molecular | 1 | 2012 | 1369 | 0.070 |
Why?
| Fatty Liver | 1 | 2009 | 210 | 0.070 |
Why?
| Short Bowel Syndrome | 1 | 2006 | 20 | 0.070 |
Why?
| Growth Hormone | 2 | 1978 | 103 | 0.070 |
Why?
| Growth | 1 | 2006 | 55 | 0.070 |
Why?
| Practice Patterns, Physicians' | 1 | 2014 | 1177 | 0.070 |
Why?
| Proteomics | 1 | 2012 | 836 | 0.070 |
Why?
| Metabolic Syndrome | 1 | 2009 | 321 | 0.060 |
Why?
| Equipment Design | 1 | 2007 | 508 | 0.060 |
Why?
| Brain | 4 | 2003 | 2371 | 0.060 |
Why?
| Pentoxifylline | 1 | 2005 | 21 | 0.060 |
Why?
| Electroencephalography | 3 | 1999 | 362 | 0.060 |
Why?
| Pituitary Gland | 2 | 1975 | 148 | 0.060 |
Why?
| Mice, Inbred BALB C | 1 | 2007 | 1144 | 0.060 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 162 | 0.060 |
Why?
| Comorbidity | 1 | 2009 | 1448 | 0.060 |
Why?
| Dietary Fats | 1 | 2006 | 287 | 0.060 |
Why?
| Cell Line | 2 | 2007 | 2637 | 0.060 |
Why?
| Estradiol | 2 | 1978 | 455 | 0.050 |
Why?
| Paraoxon | 1 | 2003 | 2 | 0.050 |
Why?
| Cells, Cultured | 3 | 2000 | 3886 | 0.050 |
Why?
| Acetylcholinesterase | 1 | 2003 | 6 | 0.050 |
Why?
| Cell Survival | 2 | 1999 | 1021 | 0.050 |
Why?
| Inflammation | 1 | 2013 | 2480 | 0.050 |
Why?
| Disease Progression | 1 | 2010 | 2380 | 0.050 |
Why?
| Receptors, Muscarinic | 1 | 2003 | 17 | 0.050 |
Why?
| Naltrexone | 1 | 2003 | 83 | 0.050 |
Why?
| Analgesics, Non-Narcotic | 1 | 2003 | 120 | 0.050 |
Why?
| Cecum | 1 | 2022 | 32 | 0.050 |
Why?
| Drug Administration Routes | 1 | 2002 | 40 | 0.050 |
Why?
| Mathematics | 1 | 2002 | 101 | 0.050 |
Why?
| Endosonography | 1 | 2023 | 140 | 0.050 |
Why?
| Tissue Distribution | 1 | 2002 | 286 | 0.050 |
Why?
| Disease Management | 2 | 2019 | 560 | 0.050 |
Why?
| Area Under Curve | 1 | 2002 | 274 | 0.050 |
Why?
| Ileum | 1 | 2022 | 90 | 0.050 |
Why?
| Magnetic Resonance Imaging | 3 | 2021 | 3052 | 0.050 |
Why?
| Delphi Technique | 1 | 2022 | 160 | 0.050 |
Why?
| Analysis of Variance | 2 | 2003 | 1226 | 0.050 |
Why?
| Pharmaceutical Preparations | 3 | 1978 | 165 | 0.050 |
Why?
| Behavior | 1 | 2001 | 92 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 5 | 2003 | 1842 | 0.050 |
Why?
| Anions | 1 | 2000 | 30 | 0.040 |
Why?
| Nasal Provocation Tests | 1 | 1999 | 3 | 0.040 |
Why?
| Calmodulin | 1 | 1999 | 71 | 0.040 |
Why?
| Personality Inventory | 1 | 1999 | 131 | 0.040 |
Why?
| Administration, Topical | 1 | 2019 | 138 | 0.040 |
Why?
| Video Recording | 1 | 1999 | 143 | 0.040 |
Why?
| Odorants | 1 | 1999 | 128 | 0.040 |
Why?
| Lipid Peroxidation | 1 | 1999 | 139 | 0.040 |
Why?
| Tomography, X-Ray Computed | 1 | 1987 | 2286 | 0.040 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 260 | 0.040 |
Why?
| Gene Expression Regulation | 2 | 2014 | 2320 | 0.040 |
Why?
| Mice | 2 | 2019 | 14869 | 0.040 |
Why?
| DNA, Mitochondrial | 1 | 2019 | 182 | 0.040 |
Why?
| Surveys and Questionnaires | 2 | 2023 | 4623 | 0.040 |
Why?
| Histocytochemistry | 1 | 2017 | 78 | 0.040 |
Why?
| Temporal Lobe | 1 | 1998 | 79 | 0.040 |
Why?
| Contraindications, Procedure | 1 | 2017 | 11 | 0.040 |
Why?
| Cell Division | 1 | 1999 | 758 | 0.030 |
Why?
| Morphine Derivatives | 2 | 1975 | 13 | 0.030 |
Why?
| Intracellular Fluid | 2 | 2003 | 27 | 0.030 |
Why?
| Phenytoin | 1 | 1996 | 14 | 0.030 |
Why?
| Castration | 4 | 1978 | 14 | 0.030 |
Why?
| Treatment Refusal | 1 | 2017 | 85 | 0.030 |
Why?
| North America | 1 | 2017 | 256 | 0.030 |
Why?
| Prodrugs | 1 | 1996 | 42 | 0.030 |
Why?
| Heart Valves | 1 | 2015 | 41 | 0.030 |
Why?
| Steroid Hydroxylases | 1 | 1975 | 19 | 0.030 |
Why?
| Mouth | 1 | 2015 | 70 | 0.030 |
Why?
| Interleukin-1 | 1 | 1999 | 966 | 0.030 |
Why?
| Single-Blind Method | 1 | 2015 | 258 | 0.030 |
Why?
| Adrenal Glands | 1 | 1975 | 66 | 0.030 |
Why?
| Laxatives | 1 | 2014 | 17 | 0.030 |
Why?
| Phosphorylation | 1 | 1999 | 1569 | 0.030 |
Why?
| Anticonvulsants | 1 | 1996 | 179 | 0.030 |
Why?
| Coronary Artery Bypass | 1 | 2015 | 196 | 0.030 |
Why?
| Fluticasone | 1 | 2014 | 87 | 0.030 |
Why?
| Fissure in Ano | 1 | 2013 | 2 | 0.030 |
Why?
| Pruritus Ani | 1 | 2013 | 2 | 0.030 |
Why?
| Suppuration | 1 | 2013 | 8 | 0.030 |
Why?
| Energy Metabolism | 1 | 1999 | 731 | 0.030 |
Why?
| Remission Induction | 1 | 2014 | 233 | 0.030 |
Why?
| Double-Blind Method | 2 | 2014 | 1660 | 0.030 |
Why?
| Reperfusion Injury | 1 | 2015 | 255 | 0.030 |
Why?
| Hypophysectomy | 4 | 1978 | 15 | 0.030 |
Why?
| Neodymium | 1 | 2012 | 1 | 0.030 |
Why?
| Organ Size | 5 | 1978 | 436 | 0.030 |
Why?
| Fecal Incontinence | 1 | 2013 | 73 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2014 | 718 | 0.020 |
Why?
| Drug Interactions | 1 | 1993 | 338 | 0.020 |
Why?
| Brain Injuries | 1 | 1996 | 461 | 0.020 |
Why?
| Nutrition Assessment | 1 | 2011 | 75 | 0.020 |
Why?
| Data Collection | 1 | 2014 | 620 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 4694 | 0.020 |
Why?
| Dantrolene | 1 | 1988 | 5 | 0.020 |
Why?
| Gallic Acid | 1 | 1988 | 13 | 0.020 |
Why?
| Cytosol | 1 | 1988 | 208 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2015 | 6347 | 0.020 |
Why?
| Pain | 1 | 2013 | 705 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2014 | 1518 | 0.020 |
Why?
| Carbon Radioisotopes | 1 | 2006 | 36 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2014 | 2539 | 0.020 |
Why?
| Palmitates | 1 | 2006 | 16 | 0.020 |
Why?
| Breeding | 1 | 2006 | 55 | 0.020 |
Why?
| Lipoprotein Lipase | 1 | 2006 | 54 | 0.020 |
Why?
| Intestinal Absorption | 1 | 2006 | 93 | 0.020 |
Why?
| Aniline Hydroxylase | 2 | 1975 | 2 | 0.020 |
Why?
| Ethylmorphine-N-Demethylase | 2 | 1975 | 2 | 0.020 |
Why?
| Biomarkers | 1 | 2015 | 3408 | 0.020 |
Why?
| Dietary Carbohydrates | 1 | 2006 | 138 | 0.020 |
Why?
| Body Height | 1 | 2006 | 180 | 0.020 |
Why?
| Transplantation, Homologous | 1 | 2006 | 377 | 0.020 |
Why?
| Testis | 2 | 1975 | 133 | 0.020 |
Why?
| Carbon Dioxide | 1 | 2006 | 218 | 0.010 |
Why?
| Triglycerides | 1 | 2006 | 467 | 0.010 |
Why?
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2003 | 17 | 0.010 |
Why?
| Rabbits | 1 | 2005 | 733 | 0.010 |
Why?
| Quinuclidinyl Benzilate | 1 | 2003 | 2 | 0.010 |
Why?
| Thymidine | 1 | 2003 | 58 | 0.010 |
Why?
| Egtazic Acid | 1 | 2003 | 44 | 0.010 |
Why?
| Tritium | 1 | 2003 | 66 | 0.010 |
Why?
| Autoradiography | 1 | 2003 | 70 | 0.010 |
Why?
| Radioligand Assay | 1 | 2003 | 43 | 0.010 |
Why?
| In Vitro Techniques | 2 | 2003 | 1016 | 0.010 |
Why?
| Neostriatum | 1 | 2003 | 29 | 0.010 |
Why?
| Chelating Agents | 1 | 2003 | 65 | 0.010 |
Why?
| Culture Media | 1 | 2003 | 155 | 0.010 |
Why?
| Adipose Tissue | 1 | 2006 | 545 | 0.010 |
Why?
| Corpus Striatum | 1 | 2003 | 126 | 0.010 |
Why?
| Narcotic Antagonists | 1 | 2003 | 136 | 0.010 |
Why?
| Brain Stem | 1 | 2003 | 101 | 0.010 |
Why?
| Middle Aged | 3 | 2015 | 26737 | 0.010 |
Why?
| Thalamus | 1 | 2003 | 74 | 0.010 |
Why?
| Sex Characteristics | 1 | 2006 | 640 | 0.010 |
Why?
| Aged | 2 | 2015 | 19074 | 0.010 |
Why?
| Aniline Compounds | 2 | 1978 | 70 | 0.010 |
Why?
| Memory | 1 | 2001 | 211 | 0.010 |
Why?
| Thapsigargin | 1 | 1999 | 18 | 0.010 |
Why?
| Calcimycin | 1 | 1999 | 47 | 0.010 |
Why?
| Cerebral Cortex | 1 | 2003 | 380 | 0.010 |
Why?
| Phenotype | 1 | 2006 | 2796 | 0.010 |
Why?
| Imidazoles | 1 | 1999 | 208 | 0.010 |
Why?
| Hippocampus | 1 | 2003 | 693 | 0.010 |
Why?
| Ethylmorphine | 1 | 1978 | 1 | 0.010 |
Why?
| Discriminant Analysis | 1 | 1998 | 37 | 0.010 |
Why?
| Seizures, Febrile | 1 | 1998 | 19 | 0.010 |
Why?
| Learning | 1 | 2001 | 350 | 0.010 |
Why?
| Thyroxine | 1 | 1978 | 56 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 2006 | 1473 | 0.010 |
Why?
| Functional Laterality | 1 | 1998 | 198 | 0.010 |
Why?
| Motor Activity | 1 | 2001 | 640 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 1999 | 750 | 0.010 |
Why?
| Injections, Intramuscular | 1 | 1996 | 116 | 0.010 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 1998 | 473 | 0.010 |
Why?
| Pregnenolone | 1 | 1975 | 2 | 0.010 |
Why?
| Vitamin A Deficiency | 1 | 1975 | 27 | 0.010 |
Why?
| Prolactin | 1 | 1975 | 96 | 0.010 |
Why?
| Adrenocorticotropic Hormone | 1 | 1975 | 128 | 0.010 |
Why?
| Corticosterone | 1 | 1975 | 211 | 0.010 |
Why?
| Ovary | 1 | 1975 | 191 | 0.010 |
Why?
| Adrenal Cortex Hormones | 1 | 1975 | 497 | 0.010 |
Why?
| Prognosis | 1 | 1998 | 3329 | 0.010 |
Why?
| Mixed Function Oxygenases | 1 | 1978 | 36 | 0.000 |
Why?
| Thyroidectomy | 1 | 1978 | 53 | 0.000 |
Why?
| Proteins | 1 | 1975 | 908 | 0.000 |
Why?
|
|
Kramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|